Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen, Sara M. Tolaney, Nancy U. Lin, Nancy Wang, Ugonma Chukwueke, Michael White, Naema Nayyar, Albert Kim, Christopher Alvarez‐Breckenridge, Ian E. Krop, Maura Mahar, Mia Bertalan, Brian Shaw, Joana L. Mora, Nathaniel Goss, Megha Subramanian, Lakshmi Nayak, Jörg Dietrich, Deborah Forst, Brian V. Nahed, Tracy T. Batchelor, Helen A. Shih, Elizabeth R. Gerstner, Beverly Moy, Donald P. Lawrence, Anita Giobbie‐Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan
Topics & Concepts
PembrolizumabOpen labelMedicineOncologyInternal medicineClinical trialCancerImmunotherapyBrain Metastases and TreatmentGlioma Diagnosis and TreatmentLung Cancer Research Studies